Source: FDA, National Drug Code (US) Revision Year: 2020
Effexor XR is an extended-release capsule for once-a-day oral administration that contains venlafaxine hydrochloride, a serotonin and norepinephrine reuptake inhibitor (SNRI).
Venlafaxine is designated (R/S)1[2-(dimethylamino)1(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (±)1[α- [(dimethylamino)methyl]-p-methoxybenzyl] cyclohexanol hydrochloride and has the empirical formula of C17H27NO2 HCl. Its molecular weight is 313.86. The structural formula is shown as follows:
Venlafaxine hydrochloride is a white to off-white crystalline solid, with a solubility of 572 mg/mL in water (adjusted to ionic strength of 0.2 M with sodium chloride). Its octanol:water (0.2 M sodium chloride) partition coefficient is 0.43.
Drug release is controlled by diffusion through the coating membrane on the spheroids and is not pH-dependent. Capsules contain venlafaxine hydrochloride equivalent to 37.5 mg, 75 mg, or 150 mg venlafaxine. Inactive ingredients consist of cellulose, ethylcellulose, gelatin, hypromellose, iron oxide, and titanium dioxide.
Dosage Forms and Strengths |
---|
Effexor XR (venlafaxine hydrochloride) extended-release capsules are available in the following strengths:
|
How Supplied |
---|
Effexor XR (venlafaxine hydrochloride) extended-release capsules are available as follows:
NDC 55289-277-30, bottle of 30 capsules. |
Drug | Countries | |
---|---|---|
EFFEXOR | Canada, France, Japan, Tunisia, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.